BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 25172355)

  • 1. Epitope-based approaches to a universal influenza vaccine.
    Gottlieb T; Ben-Yedidia T
    J Autoimmun; 2014 Nov; 54():15-20. PubMed ID: 25172355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pandemic preparedness: toward a universal influenza vaccine.
    Roose K; Fiers W; Saelens X
    Drug News Perspect; 2009 Mar; 22(2):80-92. PubMed ID: 19330167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emerging influenza viruses and the prospect of a universal influenza virus vaccine.
    Krammer F
    Biotechnol J; 2015 May; 10(5):690-701. PubMed ID: 25728134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal H1N1 influenza vaccine development: identification of consensus class II hemagglutinin and neuraminidase epitopes derived from strains circulating between 1980 and 2011.
    Moise L; Terry F; Ardito M; Tassone R; Latimer H; Boyle C; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Jul; 9(7):1598-607. PubMed ID: 23846304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Priming by a novel universal influenza vaccine (Multimeric-001)-a gateway for improving immune response in the elderly population.
    Atsmon J; Caraco Y; Ziv-Sefer S; Shaikevich D; Abramov E; Volokhov I; Bruzil S; Haima KY; Gottlieb T; Ben-Yedidia T
    Vaccine; 2014 Oct; 32(44):5816-23. PubMed ID: 25173483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination against influenza: role and limitations in pandemic intervention plans.
    Rebmann T; Zelicoff A
    Expert Rev Vaccines; 2012 Aug; 11(8):1009-19. PubMed ID: 23002981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccines for influenza virus.
    Tripp RA; Tompkins SM
    Curr Opin Investig Drugs; 2008 Aug; 9(8):836-45. PubMed ID: 18666031
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccines against highly pathogenic influenza viruses of the avian origin].
    Sergeeva MV; Romanova IuR
    Vopr Virusol; 2013; 58(4):4-9. PubMed ID: 24354058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. M2e-based universal influenza A vaccine.
    Fiers W; De Filette M; El Bakkouri K; Schepens B; Roose K; Schotsaert M; Birkett A; Saelens X
    Vaccine; 2009 Oct; 27(45):6280-3. PubMed ID: 19840661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lessons from pandemic influenza A(H1N1): the research-based vaccine industry's perspective.
    Abelin A; Colegate T; Gardner S; Hehme N; Palache A
    Vaccine; 2011 Feb; 29(6):1135-8. PubMed ID: 21115061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenicity of an MF59(®)-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly.
    Vesikari T; Forstén A; Herbinger KH; Cioppa GD; Beygo J; Borkowski A; Groth N; Bennati M; von Sonnenburg F
    Vaccine; 2012 Feb; 30(7):1388-96. PubMed ID: 22192847
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza vaccines: the good, the bad, and the eggs.
    Schultz-Cherry S; Jones JC
    Adv Virus Res; 2010; 77():63-84. PubMed ID: 20951870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New vaccine approaches for seasonal and pandemic influenza.
    Palache B
    Vaccine; 2008 Nov; 26(49):6232-6. PubMed ID: 18674583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of vaccine viruses against pandemic A(H1N1) influenza.
    Robertson JS; Nicolson C; Harvey R; Johnson R; Major D; Guilfoyle K; Roseby S; Newman R; Collin R; Wallis C; Engelhardt OG; Wood JM; Le J; Manojkumar R; Pokorny BA; Silverman J; Devis R; Bucher D; Verity E; Agius C; Camuglia S; Ong C; Rockman S; Curtis A; Schoofs P; Zoueva O; Xie H; Li X; Lin Z; Ye Z; Chen LM; O'Neill E; Balish A; Lipatov AS; Guo Z; Isakova I; Davis CT; Rivailler P; Gustin KM; Belser JA; Maines TR; Tumpey TM; Xu X; Katz JM; Klimov A; Cox NJ; Donis RO
    Vaccine; 2011 Feb; 29(9):1836-43. PubMed ID: 21199698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA-based influenza vaccines as immunoprophylactic agents toward universality.
    Zhang H; El Zowalaty ME
    Future Microbiol; 2016; 11(1):153-64. PubMed ID: 26673424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Perspective on Nanoparticle Universal Influenza Vaccines.
    Deng L; Wang BZ
    ACS Infect Dis; 2018 Dec; 4(12):1656-1665. PubMed ID: 30394725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pandemic influenza vaccines: from the lab to ethical policy making].
    Grotto I; Levine H; Balicer RD
    Harefuah; 2009 Oct; 148(10):672-6, 735. PubMed ID: 20073393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA-based influenza vaccines: evaluating their potential to provide universal protection.
    Choo AY; Broderick KE; Kim JJ; Sardesai NY
    IDrugs; 2010 Oct; 13(10):707-12. PubMed ID: 20878593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of seasonal vaccine hemagglutinin subtype 1 (H1) epitopes in Mexican isolates of the new influenza A (H1N1) 2009 virus.
    Rodríguez-Alvarez M; Velasco-Velasco AM; Alvarez-Anell NJ; Jiménez-Corona ME; de León-Rosales SP
    Arch Med Res; 2009 Nov; 40(8):687-92. PubMed ID: 20304258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaccination strategies to protect children against seasonal and pandemic influenza.
    Rimmelzwaan GF; Bodewes R; Osterhaus AD
    Vaccine; 2011 Oct; 29(43):7551-3. PubMed ID: 21820479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.